# Janus Henderson Global Life Sciences Fund

Janus Henderson Global Life Sciences Fund is a registered fund series of JANUS INVESTMENT FUND (series S000010494). Net assets $5.2B as of 2026-03-31.

## Profile

- Series ID: S000010494
- Registrant: JANUS INVESTMENT FUND
- LEI: 5493001MPP2BKRJEGV73
- Net assets: $5.2B
- Total assets: $5.2B
- As of: 2026-03-31

## Advisers

- [JANUS HENDERSON INVESTORS US LLC (Advisor)](https://search.stillhousedata.com/firm/104652)

## Top holdings (104 reported)

_Showing 15 of 104 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [Eli Lilly & Co.](https://search.stillhousedata.com/security/532457108) | — | $459.4M | 883.94% |
| [Johnson & Johnson](https://search.stillhousedata.com/security/478160104) | — | $378.9M | 729.12% |
| [AstraZeneca PLC](https://search.stillhousedata.com/security/G0593M107) | — | $238.6M | 459.15% |
| [AbbVie Inc.](https://search.stillhousedata.com/security/00287Y109) | — | $210.5M | 405.07% |
| [UnitedHealth Group Inc.](https://search.stillhousedata.com/security/91324P102) | — | $162.7M | 313.03% |
| [Novartis AG](https://search.stillhousedata.com/security/66987V109) | — | $148.4M | 285.56% |
| [Thermo Fisher Scientific Inc](https://search.stillhousedata.com/security/883556102) | — | $130.4M | 250.88% |
| [Praxis Precision Medicines Inc](https://search.stillhousedata.com/security/74006W207) | — | $127.3M | 244.85% |
| [Argenx SE](https://search.stillhousedata.com/security/04016X101) | — | $124.7M | 240.03% |
| [Abbott Laboratories](https://search.stillhousedata.com/security/002824100) | — | $124.5M | 239.52% |
| [Bridgebio Pharma Inc](https://search.stillhousedata.com/security/10806X102) | — | $115.2M | 221.63% |
| [Roche Holding AG](https://search.stillhousedata.com/security/H69293266) | — | $114.9M | 221.07% |
| [Sanofi SA](https://search.stillhousedata.com/security/F5548N101) | — | $107.7M | 207.27% |
| [Vertex Pharmaceuticals Incorporated](https://search.stillhousedata.com/security/92532F100) | — | $107.1M | 206.14% |
| [Revolution Medicines Inc](https://search.stillhousedata.com/security/76155X100) | — | $105.8M | 203.59% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-03-31 | $5.2B |
| 2025-12-31 | $5.4B |
| 2025-09-30 | $4.6B |
| 2025-06-30 | $4.4B |
| 2025-03-31 | $4.7B |
| 2024-12-31 | $4.8B |
| 2024-09-30 | $5.7B |
| 2024-06-30 | $5.5B |

## More

- [Registrant: JANUS INVESTMENT FUND](https://search.stillhousedata.com/registrant/277751)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000010494.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.